DPx Holdings B.V., owned by JLL Partners and Royal DSM, has entered a definitive agreement to acquire Gallus BioPharmaceuticals, LLC, a contract manufacturer specializing in biologics. DPx is the parent company of Patheon, DSM Fine Chemicals and Banner Life Sciences. Following the transaction, Patheon’s biologic drug substance business will have four facilities in Europe, Australia and North America, with 550 employees globally. The transaction, subject to regulatory approvals, is expected to cl...